Vyome Therapeutics
Manufacturing · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
465 Patparganj Industrial Area, Delhi, N...Phone Number
+91 9968217333Website
www.vyometx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Vyome Therapeutics
Vyome Therapeutics Inc. focuses on developing innovative treatments for immuno-inflammatory conditions and rare diseases. The company aims to empower patients by addressing unmet medical needs through unique mechanistic approaches and effective clinical trial designs. Their commitment is evident in their extensive research and clinical trials. Vyome Therapeutics targets a niche market that requires specialized medical solutions.Explore more
Vyome Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vyome Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Vyome Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Vyome Therapeutics
Check out if Vyome Therapeutics is spiking on competitors!
Earning: See what the market has to say on Vyome Therapeutics recently announced quarterly report
Check if Vyome Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Vyome Therapeutics launches new products
Vyome Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Vyome Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Vyome Therapeutics
Compare insights from companies similar to Vyome Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vyome Therapeutics
<$5M
11-50
Private
$47.3M
2017
KM
Kapil MishraSenior Director & Head of Global Business Development
Company Profile Activity
Activity Insights
Vyome Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vyome Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vyome Therapeutics.
Vyome Therapeutics financials insights
Gather financial insights about Vyome Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series A
$3.3M
2014
Series B
$8M
2016
Series C
$14M
2019
Series D
$22M
Vyome Therapeutics Tech Stack
A closer look at the technologies used by Vyome Therapeutics
See more technologies
Most Recent Scoops
Earnings
reported outstanding common shares count of 5,556,295 shares with no preferred stock, warrants, or convertible notes outstanding, maintaining a clean capital structure.
Earnings, Accounting, Financial Reporting, Stake & Stock Ownership, Finance
Earnings
reported a net loss of $9.2 million, primarily including one-time transaction and non-cash financing charges associated with the merger.
Mergers & Acquisitions, Earnings, Accounting, Financial Reporting, Acquisitions, Finance, Mergers
Project
Vyome Therapeutics is advancing VT1953 as a potential orphan drug candidate with full phase two data from its investigator-initiated trial expected in December 2025.
Product Development, Research & Development, Pharmaceuticals, Clinical Operations
Project
Vyome Therapeutics has planned FDA interactions for the first half of 2026 alongside continued development activities to advance the VT1908 program toward clinical readiness.
Product Development, Research & Development, Governmental Affairs & Regulation, Pharmaceuticals, Regulations
New Hire
Executive Move
Executive Moves, New Hire
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vyome Therapeutics
Sign Up For FreeTo access detailed company insights
Vyome Therapeutics Inc. focuses on developing innovative treatments for immuno-inflammatory conditions and rare diseases. The company aims to empower patients by addressing unmet medical needs through unique mechanistic approaches and effective clinical trial designs. Their commitment is evident in their extensive research and clinical trials. Vyom... Read More
